title: Cartilage oligomeric matrix protein in monitoring and prognostication of osteoarthritis and its utility in drug development.
abstract: Osteoarthritis (OA) is a major public concern as it is one of the leading causes of morbidity and lays a huge medical and economic burden on health resources. Early detection of OA has been a clinical challenge as early signs of joint inflammation are often not evidently identifiable on routine radiographic images. This presents a dire unmet medical need for a biomarker, which could detect early signs of joint inflammation much before irreversible joint damage and radiographic changes set in. Besides, the treatment of OA has remained mainly symptomatic. A disease modifying OA drug (DMOAD), which can act as targeted anti-OA therapy has not been able to receive regulatory approval yet. The clinical development of a DMAOD too warrants the need of a biomarker; which can act as a surrogate clinical endpoint used to monitor therapeutic efficacy and to validate a clinically meaningful change within the restricted time frame of a clinical study. In this regard, the current review focuses on cartilage oligomeric matrix protein (COMP), a potential OA biomarker which has shown significant clinical promise as a tool for early detection, therapeutic monitoring, prognostication and drug development for OA. This brief review is pivoted around the findings of selected relevant publications from PubMed indexed journals.
authors: Research and Development Division, SRL Limited, Goregaon West, Mumbai, Maharashtra, India.
authors: Bibhu R
authors: BR
authors: Das
authors: Research and Development Division, SRL Limited, Goregaon West, Mumbai, Maharashtra, India.
authors: Arnab
authors: A
authors: Roy
authors: Research and Development Division, SRL Limited, Goregaon West, Mumbai, Maharashtra, India.
authors: Faisal R
authors: FR
authors: Khan
keywords: Biomarker; cartilage oligomeric matrix protein; disease modifying osteoarthritis drug; drug development; monitoring; osteoarthritis; prognosis
references: Br J Rheumatol. 1998 Jan;37(1):46-50
references: 9487250
references: Br J Rheumatol. 1995 Apr;34(4):306-10
references: 7788143
references: Clin Rheumatol. 2005 Jun;24(3):278-84
references: 15940561
references: Biomark Insights. 2009 Feb 17;4:33-44
references: 19652761
references: Arthritis Rheum. 1999 Jan;42(1):39-45
references: 9920012
references: Curr Opin Rheumatol. 2013 Jan;25(1):136-44
references: 23169101
references: Curr Opin Rheumatol. 2011 Sep;23(5):465-70
references: 21720244
references: Int J Rheum Dis. 2011 May;14(2):113-21
references: 21518309
references: Arthritis Rheum. 2004 Aug;50(8):2479-88
references: 15334461
references: Ann Rheum Dis. 1998 Sep;57(9):527-32
references: 9849311
references: Osteoarthritis Cartilage. 2009 Dec;17 (12 ):1609-14
references: 19563924
references: Osteoarthritis Cartilage. 1998 Jan;6(1):33-9
references: 9616437
references: Bull NYU Hosp Jt Dis. 2006;64(1-2):77-81
references: 17121495
references: Osteoarthritis Cartilage. 2002 Sep;10 (9):707-13
references: 12202123
references: Ann Rheum Dis. 2001 Jun;60(6):619-26
references: 11350852
references: Rheumatol Int. 1998;18(1):21-5
references: 9672995
references: Arthritis Res Ther. 2008;10 (1):101
references: 18226182
references: HSS J. 2010 Sep;6(2):171-6
references: 21886532
references: Osteoarthritis Cartilage. 2012 Aug;20(8):854-62
references: 22595227
references: Arthritis Rheum. 1999 Nov;42(11):2356-64
references: 10555031